Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM: Oral Paclitaxel (Liporaxel) vs IV Paclitaxel in Gastric Cancer
NCT01839773Phase 3Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Mar 2013
- Primary completion
- Aug 2015
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel oral solution in gastric cancer (GC), sponsored by Daehwa Pharmaceutical Co., Ltd.. Started Mar 2013; status: completed.
02
Drugs
paclitaxel oral solution
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01839773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839773.